Trends in Remote Patient Monitoring 2013

Publication Date:           June 2013
Number of Pages:          93
Number of figures:         27
Report Price:                 $2,495 U.S. Dollars
                              
enterprise pricing available upon request

Recent news coverage
Customer testimonials

Introduction  (download paper overview)


Trends in Remote Patient Monitoring 2013 (RPM) presents the
findings of an end-user market study focused on the current state of
remote patient monitoring adoption by healthcare provider organizations
across the
United States.  The report uncovers strong opinions
regarding the market opportunities and challenges for deploying RPM
solutions to control healthcare delivery costs, improve patient outcomes
and increase patient access to care.

Trends in Remote Patient Monitoring 2013 is an outgrowth of a similar
study published by Spyglass in March 2009 entitled Trends in Remote
Patient Monitoring 2009.  Throughout this report, Spyglass traces
remote patient monitoring over the past few years identifying important
trends in the field.

The content for
Trends in Remote Patient Monitoring 2013 was
derived from more than 100 in-depth interviews with healthcare
organizations involved in telehealth/telemedicine including home health
agencies, standalone community hospitals, multi-hospital delivery
systems, government agencies and payers.

Telephone interviews were conducted over a two-month period starting
in March 2013. The purpose of the interviews was to identify the needs
and requirements for remote patient monitoring through discussions
about existing workflow inefficiencies in managing chronically ill patients,
current telehealth/telemedicine initiatives, and potential impact for
deploying remote patient monitoring in the future.

Spyglass also evaluated key vendor product offerings and identified
early adopter organizations that have successfully deployed these
solutions.



Target Audience

  • Software and hardware vendors, systems integrators and
    management consulting groups who are selling hardware,
    applications and services into the healthcare industry
  • Healthcare administrators and IT executives who are making
    strategic decision to fund clinical information technology solutions
  • Clinicians who are involved in informatics and clinical system
    evaluation and selection
  • Investment bankers and private equity investors


Abstract

Remote Patient Monitoring (RPM) solutions enable healthcare
organizations to remotely monitor and manage patients with chronic
conditions such as congestive heart failure, chronic obstructive
pulmonary disease, diabetes and asthma. RPM has been demonstrated
to significantly improve patient outcomes and reduce healthcare delivery
costs enabling healthcare providers to identify patients before their
condition(s) become more acute requiring re-hospitalization and/or
unnecessary trips to the emergency department.

RPM early adopters have been capitated managed care
organizations
with fiscal responsibility for their patients across the
continuum of care. These organizations include health maintenance
organizations, integrated delivery systems, home health agencies,
hospices, disease management companies and government agencies
like the Department of Veteran’s Affairs.  

RPM market adoption is now poised for robust growth by
healthcare provider organizations with the emergence of accountable
care.  Fifty-five percent of hospitals and health systems interviewed have
deployed or are evaluating RPM technology to address stringent
penalties focused on excessive hospital readmissions of Medicare
patients, value-based financial incentives, and new patient centered
care models.

Accountable Care Organizations face significant RPM integration
challenges.
 Fifty-eight percent of hospitals and health systems
interviewed expressed concerns about RPM integration with existing care
processes and clinical information systems.

RPM efficacy remains a controversial topic within healthcare
industry
.  More than 50 percent of hospitals and healthcare systems
interviewed questioned the clinical efficacy of RPM technology and their
anticipated financial return on investment.
 
Spyglass Consulting Group
Market Intelligence for Competitive Advantage